
COVID-19 and What Multiple Myeloma Patients Need to Know
Joshua Richter, MD
Tisch Cancer Institute, Mount Sinai
Interview Date: March 20, 2020
The coronavirus is on the minds of global citizens and all myeloma patients. Dr. Joshua Richter shares an incredible amount of information for myeloma patients to navigate their care in these uncertain times. He shares drugs patients may want to ask their doctors about, considerations for stem cell transplant, the status of some myeloma clinical trials, tradeoffs of using IVIG, and potential therapies being used to treat the coronavirus. This is a must-read show to learn how the coronavirus is affecting myeloma patients and how they can be prepared.
Thanks to our episode sponsor

Joshua Richter, MD
Tisch Cancer Institute, Mount Sinai
Interview Date: March 20, 2020
The coronavirus is on the minds of global citizens and all myeloma patients. Dr. Joshua Richter shares an incredible amount of information for myeloma patients to navigate their care in these uncertain times. He shares drugs patients may want to ask their doctors about, considerations for stem cell transplant, the status of some myeloma clinical trials, tradeoffs of using IVIG, and potential therapies being used to treat the coronavirus. This is a must-read show to learn how the coronavirus is affecting myeloma patients and how they can be prepared.
Thanks to our episode sponsor


Joshua Richter, MD

Jennifer Ahlstrom